The significance of testosterone for fair participation of the female sex in competitive sports.
作者信息
Gooren Louis
机构信息
VU University Medical Center, Amsterdam, The Netherlands.
出版信息
Asian J Androl. 2011 Sep;13(5):653-4. doi: 10.1038/aja.2011.91. Epub 2011 Jul 4.
Abstract
摘要
相似文献
1
The significance of testosterone for fair participation of the female sex in competitive sports.
Asian J Androl. 2011 Sep;13(5):653-4. doi: 10.1038/aja.2011.91. Epub 2011 Jul 4.
2
[Sports participation and fair play].
Psicothema. 2007 Feb;19(1):57-64.
3
Olympic sports and transsexuals.
Asian J Androl. 2008 May;10(3):427-32. doi: 10.1111/j.1745-7262.2008.00378.x.
4
Testosterone treatment of hypogonadal men participating in competitive sports.
Andrologia. 2008 Jun;40(3):195-9. doi: 10.1111/j.1439-0272.2008.00838.x.
5
The link between competitive sports and gambling behaviors among youths.
Am J Addict. 2015 Apr;24(3):200-202. doi: 10.1111/ajad.12189. Epub 2015 Feb 4.
6
Testosterone, cortisol, and mood in a sports team competition.
Horm Behav. 1999 Feb;35(1):55-62. doi: 10.1006/hbeh.1998.1496.
7
A sex difference in the predisposition for physical competition: males play sports much more than females even in the contemporary U.S.
PLoS One. 2012;7(11):e49168. doi: 10.1371/journal.pone.0049168. Epub 2012 Nov 14.
8
SPORTS PREFERENCE AND DIGIT RATIO (2D:4D) AMONG FEMALE STUDENTS IN WROCŁAW, POLAND.
J Biosoc Sci. 2017 Sep;49(5):623-633. doi: 10.1017/S0021932016000523. Epub 2016 Oct 11.
9
Making sense of fairness in sports.
Hastings Cent Rep. 2010 Mar-Apr;40(2):13-5. doi: 10.1353/hcr.0.0241.
10
Testosterone, territoriality, and the 'home advantage'.
Physiol Behav. 2003 Feb;78(2):269-75. doi: 10.1016/s0031-9384(02)00969-1.
引用本文的文献
1
The new policy on hyperandrogenism in elite female athletes is not about "sex testing".
J Sex Res. 2013;50(2):112-5. doi: 10.1080/00224499.2012.752429. Epub 2013 Jan 15.
本文引用的文献
1
Sex and gender issues in competitive sports: investigation of a historical case leads to a new viewpoint.
Br J Sports Med. 2012 Jun;46(8):614-7. doi: 10.1136/bjsm.2010.082552. Epub 2011 May 3.
2
Pharmacogenetics of testosterone replacement therapy.
Pharmacogenomics. 2009 Aug;10(8):1341-9. doi: 10.2217/pgs.09.58.
3
Correlates of increased lean muscle mass in women with polycystic ovary syndrome.
Eur J Endocrinol. 2009 Oct;161(4):583-9. doi: 10.1530/EJE-09-0398. Epub 2009 Jul 15.
4
The impact of assay quality and reference ranges on clinical decision making in the diagnosis of androgen disorders.
Steroids. 2008 Dec 12;73(13):1311-7. doi: 10.1016/j.steroids.2008.07.003. Epub 2008 Jul 17.
5
Testosterone treatment of hypogonadal men participating in competitive sports.
Andrologia. 2008 Jun;40(3):195-9. doi: 10.1111/j.1439-0272.2008.00838.x.
6
Androgen abuse in sports.
Asian J Androl. 2008 May;10(3):403-15. doi: 10.1111/j.1745-7262.2008.00406.x.
7
The physiological and pharmacological basis for the ergogenic effects of androgens in elite sports.
Asian J Androl. 2008 May;10(3):351-63. doi: 10.1111/j.1745-7262.2008.00407.x.
8
Hormones and sport: physiology, pharmacology and forensic science.
Asian J Androl. 2008 May;10(3):348-50. doi: 10.1111/j.1745-7262.2008.00412.x.
9
Transsexuals and competitive sports.
Eur J Endocrinol. 2004 Oct;151(4):425-9. doi: 10.1530/eje.0.1510425.
10
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).
Hum Reprod. 2004 Jan;19(1):41-7. doi: 10.1093/humrep/deh098.
Zotero 插件